Global Cell and Gene Therapy Services Supply, Demand and Key Producers, 2024-2030

Description

Cell and gene therapy services are medical services that utilize biological techniques to modify or replace human cells or genes to treat diseases. These therapies typically involve extracting a patient's cells, modifying them in a laboratory, and then re-injecting them into the patient. Cell and gene therapy services can be used to treat a variety of diseases, including cancer, genetic disorders, and infectious diseases.

The global Cell and Gene Therapy Services market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

The cell and gene therapy services industry is experiencing rapid growth. On the upstream side, research and development of biotechnology, gene editing technology, and cell culture technology are increasing, driving innovation and development in related fields. On the downstream side, as awareness of cell and gene therapy treatments improves and regulatory frameworks are refined, patient demand for these therapies is also expanding. In terms of product specifications, the types and applicability of therapies are becoming increasingly diverse, covering cancer, genetic disorders, infectious diseases, and more. The future market size is expected to continue growing, driven primarily by advancements in medical technology, an aging population, and increasing demand for personalized medicine.

This report studies the global Cell and Gene Therapy Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Services that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell and Gene Therapy Services total market, 2019-2030, (USD Million)
Global Cell and Gene Therapy Services total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cell and Gene Therapy Services total market, key domestic companies, and share, (USD Million)
Global Cell and Gene Therapy Services revenue by player, revenue and market share 2019-2024, (USD Million)
Global Cell and Gene Therapy Services total market by Type, CAGR, 2019-2030, (USD Million)
Global Cell and Gene Therapy Services total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Cell and Gene Therapy Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioIT Solutions, Lonza, SK pharmteco, Hypertrust, Qiagen, Bio-Techne, Promega, Tenthpin, Thermo Fisher, Charles River, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cell and Gene Therapy Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cell and Gene Therapy Services Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cell and Gene Therapy Services Market, Segmentation by Type
    Gene Therapy
    Cell Therapy

Global Cell and Gene Therapy Services Market, Segmentation by Application:
    Hospital
    Clinic

Companies Profiled:
    BioIT Solutions
    Lonza
    SK pharmteco
    Hypertrust
    Qiagen
    Bio-Techne
    Promega
    Tenthpin
    Thermo Fisher
    Charles River
    ACROBiosystems
    Revvity
    Pharmaron

Key Questions Answered
1. How big is the global Cell and Gene Therapy Services market?
2. What is the demand of the global Cell and Gene Therapy Services market?
3. What is the year over year growth of the global Cell and Gene Therapy Services market?
4. What is the total value of the global Cell and Gene Therapy Services market?
5. Who are the Major Players in the global Cell and Gene Therapy Services market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Cell and Gene Therapy Services Introduction
    1.2 World Cell and Gene Therapy Services Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Cell and Gene Therapy Services Total Market by Region (by Headquarter Location)
        1.3.1 World Cell and Gene Therapy Services Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Cell and Gene Therapy Services Revenue (2019-2030)
        1.3.3 China Based Company Cell and Gene Therapy Services Revenue (2019-2030)
        1.3.4 Europe Based Company Cell and Gene Therapy Services Revenue (2019-2030)
        1.3.5 Japan Based Company Cell and Gene Therapy Services Revenue (2019-2030)
        1.3.6 South Korea Based Company Cell and Gene Therapy Services Revenue (2019-2030)
        1.3.7 ASEAN Based Company Cell and Gene Therapy Services Revenue (2019-2030)
        1.3.8 India Based Company Cell and Gene Therapy Services Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cell and Gene Therapy Services Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Cell and Gene Therapy Services Consumption Value (2019-2030)
    2.2 World Cell and Gene Therapy Services Consumption Value by Region
        2.2.1 World Cell and Gene Therapy Services Consumption Value by Region (2019-2024)
        2.2.2 World Cell and Gene Therapy Services Consumption Value Forecast by Region (2025-2030)
    2.3 United States Cell and Gene Therapy Services Consumption Value (2019-2030)
    2.4 China Cell and Gene Therapy Services Consumption Value (2019-2030)
    2.5 Europe Cell and Gene Therapy Services Consumption Value (2019-2030)
    2.6 Japan Cell and Gene Therapy Services Consumption Value (2019-2030)
    2.7 South Korea Cell and Gene Therapy Services Consumption Value (2019-2030)
    2.8 ASEAN Cell and Gene Therapy Services Consumption Value (2019-2030)
    2.9 India Cell and Gene Therapy Services Consumption Value (2019-2030)

3 World Cell and Gene Therapy Services Companies Competitive Analysis
    3.1 World Cell and Gene Therapy Services Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cell and Gene Therapy Services Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy Services in 2023
        3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy Services in 2023
    3.3 Cell and Gene Therapy Services Company Evaluation Quadrant
    3.4 Cell and Gene Therapy Services Market: Overall Company Footprint Analysis
        3.4.1 Cell and Gene Therapy Services Market: Region Footprint
        3.4.2 Cell and Gene Therapy Services Market: Company Product Type Footprint
        3.4.3 Cell and Gene Therapy Services Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Cell and Gene Therapy Services Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cell and Gene Therapy Services Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Cell and Gene Therapy Services Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Services Consumption Value Comparison
        4.2.1 United States VS China: Cell and Gene Therapy Services Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Cell and Gene Therapy Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Cell and Gene Therapy Services Companies and Market Share, 2019-2024
        4.3.1 United States Based Cell and Gene Therapy Services Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cell and Gene Therapy Services Revenue, (2019-2024)
    4.4 China Based Companies Cell and Gene Therapy Services Revenue and Market Share, 2019-2024
        4.4.1 China Based Cell and Gene Therapy Services Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cell and Gene Therapy Services Revenue, (2019-2024)
    4.5 Rest of World Based Cell and Gene Therapy Services Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Cell and Gene Therapy Services Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Cell and Gene Therapy Services Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Cell and Gene Therapy Services Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Gene Therapy
        5.2.2 Cell Therapy
    5.3 Market Segment by Type
        5.3.1 World Cell and Gene Therapy Services Market Size by Type (2019-2024)
        5.3.2 World Cell and Gene Therapy Services Market Size by Type (2025-2030)
        5.3.3 World Cell and Gene Therapy Services Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Cell and Gene Therapy Services Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
    6.3 Market Segment by Application
        6.3.1 World Cell and Gene Therapy Services Market Size by Application (2019-2024)
        6.3.2 World Cell and Gene Therapy Services Market Size by Application (2025-2030)
        6.3.3 World Cell and Gene Therapy Services Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 BioIT Solutions
        7.1.1 BioIT Solutions Details
        7.1.2 BioIT Solutions Major Business
        7.1.3 BioIT Solutions Cell and Gene Therapy Services Product and Services
        7.1.4 BioIT Solutions Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 BioIT Solutions Recent Developments/Updates
        7.1.6 BioIT Solutions Competitive Strengths & Weaknesses
    7.2 Lonza
        7.2.1 Lonza Details
        7.2.2 Lonza Major Business
        7.2.3 Lonza Cell and Gene Therapy Services Product and Services
        7.2.4 Lonza Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Lonza Recent Developments/Updates
        7.2.6 Lonza Competitive Strengths & Weaknesses
    7.3 SK pharmteco
        7.3.1 SK pharmteco Details
        7.3.2 SK pharmteco Major Business
        7.3.3 SK pharmteco Cell and Gene Therapy Services Product and Services
        7.3.4 SK pharmteco Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 SK pharmteco Recent Developments/Updates
        7.3.6 SK pharmteco Competitive Strengths & Weaknesses
    7.4 Hypertrust
        7.4.1 Hypertrust Details
        7.4.2 Hypertrust Major Business
        7.4.3 Hypertrust Cell and Gene Therapy Services Product and Services
        7.4.4 Hypertrust Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Hypertrust Recent Developments/Updates
        7.4.6 Hypertrust Competitive Strengths & Weaknesses
    7.5 Qiagen
        7.5.1 Qiagen Details
        7.5.2 Qiagen Major Business
        7.5.3 Qiagen Cell and Gene Therapy Services Product and Services
        7.5.4 Qiagen Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Qiagen Recent Developments/Updates
        7.5.6 Qiagen Competitive Strengths & Weaknesses
    7.6 Bio-Techne
        7.6.1 Bio-Techne Details
        7.6.2 Bio-Techne Major Business
        7.6.3 Bio-Techne Cell and Gene Therapy Services Product and Services
        7.6.4 Bio-Techne Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Bio-Techne Recent Developments/Updates
        7.6.6 Bio-Techne Competitive Strengths & Weaknesses
    7.7 Promega
        7.7.1 Promega Details
        7.7.2 Promega Major Business
        7.7.3 Promega Cell and Gene Therapy Services Product and Services
        7.7.4 Promega Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Promega Recent Developments/Updates
        7.7.6 Promega Competitive Strengths & Weaknesses
    7.8 Tenthpin
        7.8.1 Tenthpin Details
        7.8.2 Tenthpin Major Business
        7.8.3 Tenthpin Cell and Gene Therapy Services Product and Services
        7.8.4 Tenthpin Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Tenthpin Recent Developments/Updates
        7.8.6 Tenthpin Competitive Strengths & Weaknesses
    7.9 Thermo Fisher
        7.9.1 Thermo Fisher Details
        7.9.2 Thermo Fisher Major Business
        7.9.3 Thermo Fisher Cell and Gene Therapy Services Product and Services
        7.9.4 Thermo Fisher Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Thermo Fisher Recent Developments/Updates
        7.9.6 Thermo Fisher Competitive Strengths & Weaknesses
    7.10 Charles River
        7.10.1 Charles River Details
        7.10.2 Charles River Major Business
        7.10.3 Charles River Cell and Gene Therapy Services Product and Services
        7.10.4 Charles River Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Charles River Recent Developments/Updates
        7.10.6 Charles River Competitive Strengths & Weaknesses
    7.11 ACROBiosystems
        7.11.1 ACROBiosystems Details
        7.11.2 ACROBiosystems Major Business
        7.11.3 ACROBiosystems Cell and Gene Therapy Services Product and Services
        7.11.4 ACROBiosystems Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 ACROBiosystems Recent Developments/Updates
        7.11.6 ACROBiosystems Competitive Strengths & Weaknesses
    7.12 Revvity
        7.12.1 Revvity Details
        7.12.2 Revvity Major Business
        7.12.3 Revvity Cell and Gene Therapy Services Product and Services
        7.12.4 Revvity Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Revvity Recent Developments/Updates
        7.12.6 Revvity Competitive Strengths & Weaknesses
    7.13 Pharmaron
        7.13.1 Pharmaron Details
        7.13.2 Pharmaron Major Business
        7.13.3 Pharmaron Cell and Gene Therapy Services Product and Services
        7.13.4 Pharmaron Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Pharmaron Recent Developments/Updates
        7.13.6 Pharmaron Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cell and Gene Therapy Services Industry Chain
    8.2 Cell and Gene Therapy Services Upstream Analysis
    8.3 Cell and Gene Therapy Services Midstream Analysis
    8.4 Cell and Gene Therapy Services Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Cell and Gene Therapy Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Cell and Gene Therapy Services Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Cell and Gene Therapy Services Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Cell and Gene Therapy Services Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Cell and Gene Therapy Services Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Cell and Gene Therapy Services Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Cell and Gene Therapy Services Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Cell and Gene Therapy Services Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Cell and Gene Therapy Services Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Cell and Gene Therapy Services Players in 2023
 Table 12. World Cell and Gene Therapy Services Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Cell and Gene Therapy Services Company Evaluation Quadrant
 Table 14. Head Office of Key Cell and Gene Therapy Services Players
 Table 15. Cell and Gene Therapy Services Market: Company Product Type Footprint
 Table 16. Cell and Gene Therapy Services Market: Company Product Application Footprint
 Table 17. Cell and Gene Therapy Services Mergers & Acquisitions Activity
 Table 18. United States VS China Cell and Gene Therapy Services Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Cell and Gene Therapy Services Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Cell and Gene Therapy Services Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Cell and Gene Therapy Services Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Cell and Gene Therapy Services Revenue Market Share (2019-2024)
 Table 23. China Based Cell and Gene Therapy Services Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Cell and Gene Therapy Services Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Cell and Gene Therapy Services Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Cell and Gene Therapy Services Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Cell and Gene Therapy Services Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Cell and Gene Therapy Services Revenue Market Share (2019-2024)
 Table 29. World Cell and Gene Therapy Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Cell and Gene Therapy Services Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Cell and Gene Therapy Services Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Cell and Gene Therapy Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Cell and Gene Therapy Services Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Cell and Gene Therapy Services Market Size by Application (2025-2030) & (USD Million)
 Table 35. BioIT Solutions Basic Information, Manufacturing Base and Competitors
 Table 36. BioIT Solutions Major Business
 Table 37. BioIT Solutions Cell and Gene Therapy Services Product and Services
 Table 38. BioIT Solutions Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. BioIT Solutions Recent Developments/Updates
 Table 40. BioIT Solutions Competitive Strengths & Weaknesses
 Table 41. Lonza Basic Information, Manufacturing Base and Competitors
 Table 42. Lonza Major Business
 Table 43. Lonza Cell and Gene Therapy Services Product and Services
 Table 44. Lonza Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Lonza Recent Developments/Updates
 Table 46. Lonza Competitive Strengths & Weaknesses
 Table 47. SK pharmteco Basic Information, Manufacturing Base and Competitors
 Table 48. SK pharmteco Major Business
 Table 49. SK pharmteco Cell and Gene Therapy Services Product and Services
 Table 50. SK pharmteco Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. SK pharmteco Recent Developments/Updates
 Table 52. SK pharmteco Competitive Strengths & Weaknesses
 Table 53. Hypertrust Basic Information, Manufacturing Base and Competitors
 Table 54. Hypertrust Major Business
 Table 55. Hypertrust Cell and Gene Therapy Services Product and Services
 Table 56. Hypertrust Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Hypertrust Recent Developments/Updates
 Table 58. Hypertrust Competitive Strengths & Weaknesses
 Table 59. Qiagen Basic Information, Manufacturing Base and Competitors
 Table 60. Qiagen Major Business
 Table 61. Qiagen Cell and Gene Therapy Services Product and Services
 Table 62. Qiagen Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Qiagen Recent Developments/Updates
 Table 64. Qiagen Competitive Strengths & Weaknesses
 Table 65. Bio-Techne Basic Information, Manufacturing Base and Competitors
 Table 66. Bio-Techne Major Business
 Table 67. Bio-Techne Cell and Gene Therapy Services Product and Services
 Table 68. Bio-Techne Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Bio-Techne Recent Developments/Updates
 Table 70. Bio-Techne Competitive Strengths & Weaknesses
 Table 71. Promega Basic Information, Manufacturing Base and Competitors
 Table 72. Promega Major Business
 Table 73. Promega Cell and Gene Therapy Services Product and Services
 Table 74. Promega Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Promega Recent Developments/Updates
 Table 76. Promega Competitive Strengths & Weaknesses
 Table 77. Tenthpin Basic Information, Manufacturing Base and Competitors
 Table 78. Tenthpin Major Business
 Table 79. Tenthpin Cell and Gene Therapy Services Product and Services
 Table 80. Tenthpin Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Tenthpin Recent Developments/Updates
 Table 82. Tenthpin Competitive Strengths & Weaknesses
 Table 83. Thermo Fisher Basic Information, Manufacturing Base and Competitors
 Table 84. Thermo Fisher Major Business
 Table 85. Thermo Fisher Cell and Gene Therapy Services Product and Services
 Table 86. Thermo Fisher Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Thermo Fisher Recent Developments/Updates
 Table 88. Thermo Fisher Competitive Strengths & Weaknesses
 Table 89. Charles River Basic Information, Manufacturing Base and Competitors
 Table 90. Charles River Major Business
 Table 91. Charles River Cell and Gene Therapy Services Product and Services
 Table 92. Charles River Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Charles River Recent Developments/Updates
 Table 94. Charles River Competitive Strengths & Weaknesses
 Table 95. ACROBiosystems Basic Information, Manufacturing Base and Competitors
 Table 96. ACROBiosystems Major Business
 Table 97. ACROBiosystems Cell and Gene Therapy Services Product and Services
 Table 98. ACROBiosystems Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. ACROBiosystems Recent Developments/Updates
 Table 100. ACROBiosystems Competitive Strengths & Weaknesses
 Table 101. Revvity Basic Information, Manufacturing Base and Competitors
 Table 102. Revvity Major Business
 Table 103. Revvity Cell and Gene Therapy Services Product and Services
 Table 104. Revvity Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. Revvity Recent Developments/Updates
 Table 106. Revvity Competitive Strengths & Weaknesses
 Table 107. Pharmaron Basic Information, Manufacturing Base and Competitors
 Table 108. Pharmaron Major Business
 Table 109. Pharmaron Cell and Gene Therapy Services Product and Services
 Table 110. Pharmaron Cell and Gene Therapy Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. Pharmaron Recent Developments/Updates
 Table 112. Pharmaron Competitive Strengths & Weaknesses
 Table 113. Global Key Players of Cell and Gene Therapy Services Upstream (Raw Materials)
 Table 114. Global Cell and Gene Therapy Services Typical Customers


List of Figures
 Figure 1. Cell and Gene Therapy Services Picture
 Figure 2. World Cell and Gene Therapy Services Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Cell and Gene Therapy Services Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Cell and Gene Therapy Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Cell and Gene Therapy Services Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Cell and Gene Therapy Services Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Cell and Gene Therapy Services Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Cell and Gene Therapy Services Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Cell and Gene Therapy Services Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Cell and Gene Therapy Services Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Cell and Gene Therapy Services Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Cell and Gene Therapy Services Revenue (2019-2030) & (USD Million)
 Figure 13. Cell and Gene Therapy Services Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Cell and Gene Therapy Services Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Cell and Gene Therapy Services Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Cell and Gene Therapy Services Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Cell and Gene Therapy Services Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Cell and Gene Therapy Services Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Cell and Gene Therapy Services Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Cell and Gene Therapy Services Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Cell and Gene Therapy Services Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Cell and Gene Therapy Services Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Cell and Gene Therapy Services by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Services Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Services Markets in 2023
 Figure 27. United States VS China: Cell and Gene Therapy Services Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Cell and Gene Therapy Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Cell and Gene Therapy Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Cell and Gene Therapy Services Market Size Market Share by Type in 2023
 Figure 31. Gene Therapy
 Figure 32. Cell Therapy
 Figure 33. World Cell and Gene Therapy Services Market Size Market Share by Type (2019-2030)
 Figure 34. World Cell and Gene Therapy Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 35. World Cell and Gene Therapy Services Market Size Market Share by Application in 2023
 Figure 36. Hospital
 Figure 37. Clinic
 Figure 38. World Cell and Gene Therapy Services Market Size Market Share by Application (2019-2030)
 Figure 39. Cell and Gene Therapy Services Industrial Chain
 Figure 40. Methodology
 Figure 41. Research Process and Data Source

Companies Mentioned

BioIT Solutions
Lonza
SK pharmteco
Hypertrust
Qiagen
Bio-Techne
Promega
Tenthpin
Thermo Fisher
Charles River
ACROBiosystems
Revvity
Pharmaron